How Shifting Margin Assumptions Are Rewriting The NeuroPace (NPCE) Investment Narrative [Yahoo! Finance]
Neuropace, Inc. (NPCE)
Company Research
Source: Yahoo! Finance
NeuroPace's analyst narrative has been refreshed around a price target anchored to an unchanged model fair value of $19.88 per share, indicating that the core valuation framework remains intact. The $1 adjustment in the price target reflects updated views on how the company might execute on profitability, with bullish and cautious perspectives assessing those assumptions differently. As you read on, you will see how these price target changes fit into the broader story and what to monitor as the narrative develops. Stay updated as the Fair Value for NeuroPace shifts by adding it to your watchlist or portfolio . Alternatively, explore our Community to discover new perspectives on NeuroPace. What Wall Street Has Been Saying ?? Bullish Takeaways H.C. Wainwright lifted its price target for NeuroPace by $1 while keeping a fair value framework of $19.88 per share, signaling that its core view on the company's potential earnings power and valuation drivers remains consistent. Well
Show less
Read more
Impact Snapshot
Event Time:
NPCE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NPCE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NPCE alerts
High impacting Neuropace, Inc. news events
Weekly update
A roundup of the hottest topics
NPCE
News
- NeuroPace to Present at the 25th Annual Needham Virtual Healthcare ConferenceBusiness Wire
- NeuroPace (NPCE) was upgraded by Wells Fargo & Company to "strong-buy".MarketBeat
- How The NeuroPace (NPCE) Story Is Shifting As Analysts Refresh Valuation Assumptions [Yahoo! Finance]Yahoo! Finance
- NeuroPace (NPCE) was downgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=NPCE&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "buy" to "holMarketBeat
- NeuroPace (NPCE) was upgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=NPCE&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "hold" to "buy"MarketBeat
NPCE
Earnings
- 3/3/26 - Beat
NPCE
Sec Filings
- 3/25/26 - Form 4
- 3/24/26 - Form 4
- 3/24/26 - Form 4
- NPCE's page on the SEC website